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Abstract
Background: Transition clinics (TCs) are advocated as best practice to support young
people with cystic fibrosis (CF) during transition to adulthood and adult care. We aimed
to research the functioning of a TC for young people with CF compared with direct
hand‐over care and to evaluate whether those treated at the TC have better transfer
experiences and outcomes compared with the control group.
Methods: Mixed‐methods retrospective controlled design, including interviews with
professionals, observations of clinics, chart reviews (at four measurement moments),
and patient surveys. Qualitative data analysis focused on organization and daily
routines, and barriers and facilitators experienced. Young people’s transfer
experiences, self‐management, health care use, and clinical outcomes were assessed
quantitatively.
Results: The most notable feature distinguishing the TC and direct hand‐over
care comprised joint consultations between pediatric and adult care professionals in
the former. A transition coordinator was considered essential for the success
of the TC. The main barriers were lack of time, planning, and reimbursement issues.
Young people treated at the TC tended to have better transfer experiences and were
more satisfied. They reported significantly more trust in their adult care
professionals. Their self‐management‐related outcomes were less favorable.
Conclusions: The TC had several perceived benefits and showed positive trends in
transfer experiences and satisfaction, but no differences in health‐related outcomes.
Structured preparation of young people, joint consultations with pediatric and
adult care professionals, and better coordination were perceived as facilitating
elements. Further improvement demands solutions for organizational and financial
barriers, and better embedding of self‐management interventions in CF care.
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1 | INTRODUCTION
In the Netherlands, around 1500 people live with cystic fibrosis (CF)
and more than half are over 18 years of age.1 Their life expectancy
has improved and is likely to improve further with the advent of CF
transmembrane conductance regulator modulator therapies.1,2 CF
care in the Netherlands has been concentrated in seven centers, each
with an adult and a pediatric department. Although treatment
protocols are standardized across these centers,3 differences in the
organization of care continue to exist.
Young people with CF may experience difficulty entering into
adulthood as developmental milestones can clash with the demands
of the disease.4 Independence and autonomy are compromised by
frequent pulmonary exacerbations and may accentuate the feeling of
being different from healthy peers.5 Patients should be made aware
early on in life of fertility concerns, genetic implications of CF, and
short life expectancy.5 Young people with CF also need to prepare
for the transfer from pediatric to adult‐oriented health care, which
means bridging the gap between these settings.6-8 Because this
coincides with physical and psychosocial changes, therapy adherence
may be threatened with risk of loss of pulmonary function, lowering
of body mass index (BMI), and hospitalizations.9-11 It is widely
acknowledged that young people with CF should receive the
appropriate support during the transitional phase.7,9,12,13
A transition clinic (TC) is often advocated as best practice for this
type of support.14,15 Although there is no shared model, the TC’s core
principle is that professionals from both pediatric care (PC) and adult
care (AC) deliver outpatient care in preparation for the upcoming
transfer.14 Studies evaluating TCs in CF care have reported improved
health status, self‐care and self‐advocacy skills, and more indepen-
dence.2,11,12,16-18 However, most studies did not include a controlled
pre‐post outcome evaluation, and the body of evidence
for effects is still small. Also, daily routines and protocols differ
considerably between TCs.9,14 Despite the expected positive impact,
the contributions of the different components and the experiences of
young people and professionals are still unclear.12 This study aimed
to evaluate the functioning and outcomes of a TC compared with a
control setting with direct hand‐over care. Our hypothesis is that
young people with CF treated at the TC will have more positive
transfer experiences and will show better self‐management, health
care use, and clinical outcomes around the transfer.
2 | MATERIALS AND METHODS
2.1 | Setting and design
This study involved a retrospective, controlled mixed‐methods
evaluation of a TC for young people with CF. Two of the largest CF
centers in university hospitals in the Netherlands, each treating 200 to
300 patients a year, participated. One had implemented a TC in 2009;
the other served as control setting providing direct hand‐over care.
The settings were compared on structures and daily routines, health
care use, clinical‐ and self‐management outcomes, and experiences
and satisfaction with the transfer. Experienced barriers and
facilitators for the functioning of the TC and perceived benefits
were also studied. The study protocol has been published elsewhere.19
2.2 | Participants
Health care professionals (HCPs) from relevant disciplines in both
settings were interviewed. All young people who transferred
between 2010 and 2013 (2‐4 years before data collection) were
included in a chart review and were asked to fill out a survey. Those
with known intellectual disabilities or psychiatric conditions were
excluded.
2.3 | Data collection
2.3.1 | Qualitative part
In semistructured interviews, HCPs were encouraged to share
their experiences and expectations regarding transitional care.
Topics addressed were organization and structure, facilitators
and barriers, content of consultations, use of interventions, and
potential improvements. HCPs working at the TC were also asked
about perceived benefits.
Nonparticipant observations of outpatient consultations between
young people, their parents (if present), and HCPs were conducted
at both settings. Two observations of 4 hours each were performed
at the TC and two observations of, respectively, 3 and 2 hours in
the control setting. In addition, a multidisciplinary meeting of
pediatric and adult HCPs at the TC was observed, in which they
discussed the patients’ psychosocial status. In the control setting, a
regular multidisciplinary meeting of pediatric HCPs was observed.
The observers focused on coordination of the transition process,
structure and content of consultations, interaction between involved
parties, and use of interventions.
2.3.2 | Quantitative part
A set of background, process, and outcome variables was selected
that previously had been found essential for a successful transition.19
Table 1 provides an overview of our operationalization and data
collection method per variable. Patient data from four measurement
moments were collected: T1, the 2 years before transfer; T2, the
1 year before transfer; T3, the 1 year after transfer; and T4, the
2 years after transfer. The young people who provided consent
for the chart review were invited to fill out an online survey. A
reminder was sent to nonresponders after 2 weeks, followed by a
telephone call after 4 weeks.
2.4 | Data analysis
2.4.1 | Qualitative part
Interviews were audio‐recorded and transcribed ad verbatim;
observation field notes were recorded in narratives. Atlas.ti 7.0 was
used for data analysis. Two researchers (MP and JS) independently
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analyzed the data by using the framework approach, whereby themes
addressed during the interviews and observations were leading in the
coding process. If applicable, subthemes were derived from the data.
2.4.2 | Quantitative part
Analysis of variance tests were used to investigate within‐group
differences on clinical outcomes and health care use over the four
measurement moments. Independent samples t‐tests and Pearson’s
χ2‐tests were performed to compare the TC and control setting on
chart review and survey outcomes. Effect sizes were calculated to
indicate the magnitude of the observed effects, as they are not
affected by the sample sizes, unlike P‐values (Cohen’s d = 0.2 small
effect, 0.5 medium, and 0.8 large). Spearman’s tests were used to
examine correlations. Statistical analyses were performed with IBM
SPSS 26.0.
2.5 | Ethical considerations
All young people provided written consent for the different study
parts in which they were included after they received the appropriate
information. Quantitative data were processed anonymously, and
pseudonyms were used in the interview transcripts and observation
narratives. The Medical Ethics Review Board of Erasmus Medical
Center approved the study protocol (MEC‐2014‐246).
3 | RESULTS
3.1 | Response
Ten HCPs were interviewed in the TC setting and 18 in the control
setting. Table 2 provides a description of the study sample.
3.2 | Structure and organization
In the TC setting, young people were invited for a final visit to the
pediatric clinic, including joint consultations with: (a) their current
pediatric pulmonologist and their future adultcare pulmonologist,
and (b) the nurses from both settings. This one‐time visit was
additional to the regularly scheduled multidisciplinary outpatient
visits (four times a year). In the control setting, no special
transition arrangements were arranged apart from these regular
visits. Here, young persons and their parents said farewell during
the final consultation with the pediatric pulmonologist. In the
period between the last appointment in PC and the first
appointment in AC, the pediatric pulmonologist was in charge of
treatment decisions in case of unforeseen circumstances. This
was the case in both the TC and control setting. Table 3 provides
more detailed information on the characteristics of care provision
of these two centers and their pediatric and adult clinics, and
presents the differences in structures and daily routines between
both settings.
3.3 | Interview results
3.3.1 | Perceived benefits of a TC
Professionals at the TC perceived several benefits. In PC, HCPs
appreciated the planned farewell moment. They found that prepara-
tion for transfer had improved:
“It really helps to prepare children. […] Now they know
that something is going to happen which could have a high
impact on them. That was not the case before, when it
was abrupt and we got a lot of reactions afterwards. […]
So, it is much better organized and less stressful for the
patients than before.” (TC; pulmonologist PC)
TABLE 2 Description of the total study sample
TC Direct hand‐over care P‐valuea
Professionals interviewed n = 10 n = 18
Pediatric pulmonologists (3); pediatric nurses (2);
pediatric psychologist; pediatric
psychotherapist; pulmonologist adult care;
nurse adult care; psychologist adult care
Pediatric pulmonologists (4); pediatric
gastroenterologists (2); pediatric nurses (2);
pediatric social workers (2); pediatric
psychologist; pediatric dieticians (2); pediatric
physiotherapists (2); pulmonologist adult care;
nurses adult care (2)
NA
Young people with CF n = 27 n = 19
Gender (male) 13 (48.1%) 10 (52.6%) .765
Age 22.56 (±1.22) 22.26 (±1.33) .444
Age at transferb 18.31 (±0.618) 18.36 (±0.633) .812
Department to which young
person transferred is
recorded/known (yes)
27 (100%) 18 (94.7%) .413
Abbreviations: TC, transition clinic.
aIndependent samples T‐test or the Pearson’s χ2‐test/Fischer’s exact test.
bN = 26 in the TC group and n = 14 in the control setting because, respectively, n = 1 and n = 5 respondents did not give permission for chart review.
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TABLE 3 Differences in structures and daily routines between TC setting and control setting
Characteristics of care TC setting Control setting
Location Pediatric and adult clinic are colocated on the same
campus.
Pediatric clinic is located on two different campuses in the
city, adult clinic is centralized on one of these campuses.
Electronic medical
record system (EMR)
Pediatric and adult clinic use the same EMR. Pediatric and adult clinic that are colocated on the same
campus use the same EMR; the other pediatric clinic (located
on a different campus) uses paper charts.
Transition
Team of professionals Pediatric pulmonologists, pediatric nurses, pediatric
psychologist, pediatric psychotherapist, pulmonologist
AC, nurse AC, and psychologist AC.
Pediatric pulmonologists, pediatric gastroenterologists,
pediatric nurses, pediatric social workers, pediatric
psychologist, pediatric dieticians, pediatric physiotherapists,
pulmonologists AC, and nurses AC.
Start of the transition
phase
From 12 y by using the Individual Transition Plan. Stimulating self‐management skills from 12 y, specific
attention for transfer from around 16 or 17 y.
Use of self‐
management
interventions
Knowledge tool, Cystic Fibrosis Questionnaire (CFQ),
Individual Transition Plan, independent consultations
with young people (without parents present).
Knowledge tool, Cystic Fibrosis Questionnaire (CFQ), KLIK
PROfile (a web‐based application for the use of patient
reported outcomes), independent consultations with young
people (without parents).
Transfer
Setting of effectuation Pediatric clinic. Pediatric clinic (one of the two locations).
Visitors Young people with CF aged 17 or 18 y, with or without
their parents.
Young people with CF until age of 18 y, with or without their
parents.
Working ways TC with joint consultations, written transfer (EMR). Written transfer (EMR or paper chart), multidisciplinary CF
team meeting with professionals from PC and AC (doctors,
nurses and paramedics; every month; alternately on each of
the two campuses).
Structure and
organization
1. Joint consultation with pediatric pulmonologist
and adult pulmonologist. Just before the young
person enters the consultation room, the
pulmonologists briefly talk about the patient’s
situation.
2. Joint consultation with pediatric nurse and adult
nurse.
1. Multidisciplinary pediatric CF team meeting.
2. Consultation of pediatric pulmonologist with young
person.
Topics discussed
(content)
During preliminary discussion between pulmonologists:
Pediatric pulmonologist informs the adult
pulmonologist about the young person and his/her
situation. Themes addressed are the medical situation,
independent behavior, and (relation with) parents.
During multidisciplinary team meeting: Discussion of the most
striking issues regarding patients’ current situation and
relevant historical occurrences, such as therapy adherence
and clinical outcomes, hospital admissions, self‐management
skills, risk behavior, and school situation. Not only about
transferring patients but about all children who are planned
for an outpatient visit that day.
During joint consultation of pediatric and adultcare
pulmonologist with young person (with or without parents
present): Young persons are asked about their disease
and therapy adherence, and a physical examination is
performed. Subsequently, the adult pulmonologist
explains about structures and routines in AC (ie, the
outpatient clinic and the team of professionals) and
differences with PC are discussed. Attention is paid to
young people’s responsibility regarding therapy
adherence and to social participation (eg, sport, driving
license, school, and work).
During individual consultation of pediatric pulmonologist with
young person (with or without parents present): Attention is
paid to medical subjects (ie, symptoms, treatment, and
adherence) and nonmedical subjects (ie, study, work, sport,
transition in care, and the importance of independent
behavior). Sometimes other relevant professionals—like a
physiotherapist or a psychologist—participate in the care
process, dependent on the young person’s individual
situation and needs. The overall care trajectory is
coordinated by the pediatric nurse specialist.
During joint consultation of pediatric and adultcare nurse
with young person (with or without parents present):
Focus is on preparing young persons and their parents
for the transfer to AC. Practical things are discussed,
such as the way outpatient visits are organized,
logistics, and attainability. Attention is also paid to
differences with PC; young people receive an
information bulletin about the AC setting. Moreover,
(Continues)
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“Professionals from adult care say: ‘We see different young
people and parents transferring.’ That is nice to hear.
I hear nurses and the doctor say that things went better
last years. They see changes and the transfer goes more
smoothly.” (TC; nurse PC)
The joint consultations provided HCPs from AC with a more
holistic view of the transferring patient. The pulmonologist
explained: “It is no longer the case that you just hand over the
person. Instead, ‘This is the patient as a whole: this is his disease,
this is his personality and these are goals or concerns.’ I think
that’s the secret of a good transition, that you know all these
facets.”
Moreover, using an Individual Transition Plan (ITP) from
around the age of 12 creates structure and continuity in the
preparation for transfer. “The ITPs are also transferred at the TC,
so that we are fully aware of the young persons’ preparation and
information so far, and things that need special attention from us”
(TC; nurse AC).
The TC also facilitates finetuning of the care trajectory between
PC and AC: “Two distinct worlds have to communicate with each
other, two settings. […] It is, of course, paramount that this runs
smoothly and that we know what our colleagues from PC have done
and how we can best continue” (TC; psychologist AC). HCPs in the
control setting miss such joint care arrangements: “A transition clinic,
where young people are seen by the pulmonologists and the nurses
from PC and AC, would be really valuable […]. Such a transition
process, with more intensive consultation between pediatric and
adult professionals, would improve [the quality of] care” (control;
nurse AC).
3.3.2 | Facilitators and barriers for transitional care
Professionals in the TC setting considered intrinsic motivation and
commitment as prerequisites for a successful TC.
“It is all about the willingness and the effort of a group of
people to work together.” (TC; psychotherapist PC)
“Everyone is convinced that it is better to do it this way.
Despite the busy schedules […], it’s everyone’s intention
to make time for transition.” (TC; pulmonologist AC)
Starting paying attention to transition at an early stage is
essential according to professionals from both settings. This helps
to better prepare young people and their parents for their final visit
to the pediatric clinic. Also, flexibility in the moment of transfer
is required.
“We start at the age of 12: ‘Listen, from now on you are
going to manage your medication by yourself […] because
when you reach 18, you should be able to do it on your
own.’ So, we emphasize that very often and it is no longer
a surprise. I think it is important to announce [the
transfer] far in advance and repeat it over and over.” (TC;
pulmonologist PC)
“I think we need to be more alert. We only wake up when
the date of transfer comes really close. Now it is like: ‘Oh,
he or she is 17, we have to get started with a number of
things.’ That should be earlier.” (Control; pulmonologist
PC)
Several professionals pointed out that it helps when a member of
the care team takes up a coordinating role in this process, preferably
“a dedicated nurse specialist”. This transition coordinator is not only
important for logistics, but also to ensure an early start, to serve as a
spokesperson for young people and parents, and to create a sense of
urgency for adequate transitional care in both teams.
“The nurse is often easily accessible; patients dare to tell
more to their nurse than to their doctor, also about
TABLE 3 (Continued)
Characteristics of care TC setting Control setting
the nurses suggest a guided tour to become familiar
with the new setting. After providing information and
instructions, the nurses inquire young people about
their attitude toward the upcoming transfer. They are
asked about their transfer readiness (possibly also of
their parents), their experiences with taking up
responsibility and self‐management, for instance in
self‐care, therapy adherence, and social participation
(school/work and future plans). The pediatric nurse
also asks if the young person agrees with transferring
the Individual Transition Plan to AC.
Follow‐up after
transfer within the
same hospital
By an adult pulmonologist, the same who was involved
in the TC.
By an adult pulmonologist, the same who was involved in
monthly meetings and discussions about the CF patients.
Abbreviations: AC, adult care; EMR, electronic medical record system; PC, pediatric care; TC, transition clinic.
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nonmedical issues. Nurses can act as a link between the
patient and other professionals; so that a more holistic
view of the patient can be established.” (Control;
pulmonologist AC)
Professionals also reported several barriers to the
organization and functioning of the TC. First, lack of time; their
work schedules hardly left any room for extra or longer consultations
or additional team meetings. Presently, the TC only involved one
moment of joint care, which was not always enough.
“Time is always limited while the [transition] consultation
has two goals, as we also use it for regular follow‐up [next
to preparation for the transfer].” (TC; pulmonologist PC)
“Nowadays, everyone is too busy. […] I think that
our collaboration suffers from that. Because there is
just too little time to think about things quietly and to
align or fine‐tune things.” (Control; social worker PC)
Lack of financial support is another important barrier as
transitional care is not reimbursed. One of the TC pediatric
pulmonologists illustrates this: “At regular consultation hours
you see ten children and at the transition clinic only four.” Potential
barriers may also lie within a setting’s culture, policy, and ways
of working.
“We are used to discuss and explain things, and to make
shared decisions. In adult care, information is provided,
but in the end the patient decides.” (TC; nurse PC)
“We always try to make it as easy as possible for our
patients. So, when an appointment has to be rescheduled,
I schedule a new one. […] When something is wrong with
medication, we call the pharmacy. […] This is not how it
works in adult care, where patients have to do it all by
themselves.” (Control; nurse PC)
According to some adult HCPs, PC is made “too attractive,”
pointing at the high level of involvement and sense of responsi-
bility for young persons’ health. They think that this increases
the gap and thus impedes the transfer to AC. About content of
care at the TC, professionals mentioned lack of uniformity in the
preparation trajectory, despite the use of the ITP. A pediatric
pulmonologist said: “Regularly I have consultations with youth
aged 12 to 18 in which I do not think about transition at all and no
one points this out to me.” Professionals in the control setting also
did not always address transition, thereby leaving the young
persons and their parents wondering what to expect from
transition and when it was going to happen. Furthermore,
professionals from both settings emphasized that their transitional
care would benefit from more availability of allied health
professionals, more attention for psychosocial aspects, and more
independent consultations (without parents).
3.4 | Transfer experiences and satisfaction with
transition
Analysis revealed a trend of higher scores for transfer experiences among
those treated at the TC compared with those treated in direct hand‐over
care. The difference was not statistically significant; the effect size was
medium (d=0.48). The same was the case for reported satisfaction
with transition (d=0.68) (Table 4). Looking at individual items of the
Transfer Experiences Scale (5‐point Likert scales; 1 = strongly disagree,
5 = strongly agree), young people treated at the TC had more often met
their adult HCPs before transfer (3.73 ±1.27 vs. 2.14 ±1.23, P< .01;
d=1.25) and reported more trust in their adult HCPs (4.73 ± 0.467 vs.
4.21 ±0.426, P< .01; d=1.11). They assigned higher scores to the
experienced alignment in the ways of working and dealings between PC
and AC (3.45 ± 1.13 vs. 2.93 ± 0.917). This difference was
TABLE 4 Differences in health care and self‐management related outcomes
TC (n = 11)a Control setting (n = 14)b Effect sizec P‐valued
Health carerelated
Transfer experiences (OYOF‐TES) 71.73 (±8.84) 67.50 (±7.83) 0.48 .218
Satisfaction with transition (VAS; range 1‐10) 8.00 (±1.27) 7.14 (±1.03) 0.68 .074
Perceived patient‐centeredness of care (CAHPS) 17.60 (±2.07) 17.57 (±2.74) 0.01 .978
Self‐management related
Self‐management skills (PIH) 78.00 (±8.41)e 83.29 (±6.43) −0.63 .094
Independence during consultations (range 1‐10) (IBDCS) 8.67 (±0.866)f 9.29 (±0.914) −0.68 .121
Self‐efficacy (OYOF‐SES) 57.90 (±3.00)e 56.00 (±10.93) 0.17 .600
Adherence to treatment (MARS‐5) 21.80 (±2.20)e 20.00 (±3.49) 0.52 .165
Health‐related quality of life (PedsQL‐YA) 72.17 (±14.44)e 73.84 (±18.53) −0.09 .815
Abbreviation: TC, transition clinic.
an = 11 (40.7%) responded to the survey.
bn = 14 (73.7%) responded to the survey.
cCohen’s d (based on largest SD).
dIndependent samples T‐test.
en = 10.
fn = 9.
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not significant; the effect size was medium (d= 0.46). There was no
difference in perceived patient‐centeredness of adult HCPs.
3.5 | Self‐management related outcomes
There were no significant differences regarding self‐management.
Still, effect sizes show some trends. Young people in the TC setting
tended to report better medication adherence than those in the
control setting (d = 0.52) (Table 4). However, they also tended to
report lower scores on self‐management and independence during
consultations; effect sizes were medium (respectively d = −0.63 and
d = −0.68).
3.6 | Differences in health care use and clinical
outcomes
Young people who received care at the TC were significantly more
often admitted to hospital in the two years after transfer than those
in direct hand‐over care (P = .045, d = 0.45) (Table 5). This may be
related to poorer pulmonary functioning, as they had lower FEV1%
predicted over the whole period compared with those in the control
setting. Before transfer, these differences were not statistically
significant; effect sizes were medium (T1: P = .173, d = −0.40; T2:
P = .145, d = −0.49). After transfer, the differences were significant
with large effect sizes (T3: P = .003, d = −1.03; T4: P = .007, d = −1.06).
Within‐subject analyses showed a significant linear decrease of
FEV1% predicted over the four measurement moments in the TC
group (F(2.22, 40.03) = 5.89, P = .004). There was no significant
difference in FEV1% predicted over time within the control group.
The correlation between pulmonary functioning and satisfaction with
transition was not significant (rs = 0.298, P = .203).
4 | DISCUSSION
In this study, we found that joint consultations between professionals
from PC and AC are generally preferred over direct hand‐over
transfer, and that having a dedicated transition coordinator is
important in transitional care. This is confirmed in several other
studies.20-22 A coordinator at both sites of transition helps to secure
organizational and health care related issues, given the array of new
services that were to be accessed.21 For successful transitional care,
it also appears essential to address transition and self‐management
TABLE 5 Differences in health care use and clinical outcomes
TC Control setting Effect sizea P‐valueb
No‐show at first appointment in ACc
n = 26 1 (3.8%) NA NA NA NA
No. of hospital admissions
T1 n = 26 0.65 (±1.13) n = 14 0.36 (±0.842) 0.26 .395
T2 n = 26 0.58 (±1.10) n = 14 0.43 (±1.09) 0.14 .686
T3 n = 26 0.54 (±0.811) n = 12 0.50 (±0.798) 0.05 .892
T4d n = 26 0.54 (±1.03) n = 12 0.08 (±0.289) 0.45 .045
No. of emergency department visits
T1 n = 26 0.23 (±0.815) n = 14 0.07 (±0.267) 0.19 .484
T2 n = 26 0.31 (±1.05) n = 14 0.21 (±0.579) 0.09 .760
T3 n = 26 0.04 (±0.196) n = 12 0.58 (±0.996) −0.54 .086
T4 n = 26 0 n = 12 0.08 (±0.289) −0.28 .339
FEV1% predictede
T1 n = 25 78.11 (±18.54) n = 12 88.41 (±25.84) −0.40 .173
T2 n = 23 73.88 (±17.28) n = 12 87.55 (±28.16) −0.49 .145
T3 n = 24 70.48 (±19.07) n = 10 94.89 (±23.59) −1.03 .003
T4 n = 22 67.56 (±22.51) n = 10 93.08 (±24.15) −1.06 .007
No. of acute exacerbations
T1 n = 27 0.67 (±0.832) n = 14 1.29 (±1.98) −0.31 .280
T2 n = 23 0.35 (±0.775) n = 14 1.86 (±2.57) −0.59 .050
T3 n = 25 0.76 (±1.27) n = 12 0.75 (±1.49) 0.01 .983
T4 n = 25 0.72 (±1.28) n = 12 0.50 (±0.798) 0.17 .588
BMI
T1 n = 25 21.02 (±2.14) n = 12 20.45 (±2.42) 0.24 .473
T2 n = 24 21.22 (±2.19) n = 12 20.68 (±3.00) 0.18 .544
T3 n = 16 20.62 (±2.60) n = 6 22.34 (±2.84) −0.61 .193
T4 n = 17 20.94 (±3.04) n = 6 22.36 (±2.62) −0.47 .321
Abbreviations: BMI, body mass index; TC, transition clinic.
aCohen’s d (based on largest SD).
bIndependent samples T‐test or Pearson’s χ2‐test.
cNo data available from the control setting, except that we know that one of the patients was lost to follow‐up after transfer.
dT1: 2 years before transfer; T2: 1 year before transfer; T3: 1 year after transfer; T4: 2 years after transfer.
eCalculation based on guidelines of the Global Lung Function Initiative (http://gligastransfer.org.au/calcs/spiro.html).
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skills from an early age on. The interviewed professionals perceived
several benefits of the TC, such as obtaining a holistic view of the
transferring patient and fine‐tuning of care between the settings.
Professionals also noted that young people and their parents had
more confidence in the transfer since they started seeing them at the
TC. Indeed, the young people treated at the TC reported significantly
more trust in their adult HCPs than those receiving direct hand‐over
care. This is probably because the former had met their new HCPs
more often before transfer, which is considered one of the most
effective mechanisms of transition programs.12,23
A contra‐intuitive outcome of our study was that young
people in the TC group had lower scores on self‐management
outcomes compared with those in the control group. The
qualitative study revealed that self‐management interventions
(eg, ITPs) are not always used as intended. When embedded in
routine, ITPs can facilitate the discussion about patient’s and
parents’ perceptions of transition readiness.13 Besides this, it is
important to provide young people with room for mastering self‐
management tasks, eg, by organizing independent consultations
with young people alone (without parents) more frequently
during the transition phase.24 It remains a misconception,
however, that young patients are all on their own when they
transfer to AC. Our results showed that pediatric HCPs still take
over young people’s responsibilities, instead of encouraging them
toward more independence. Pediatric HCPs may be projecting
their own concerns onto their young patients, thereby hindering
patient empowerment.12,25
Many professionals mentioned lack of time, planning difficulties,
and reimbursement issues as barriers for the organization and
functioning of a TC. These organizational barriers are not unique to
the CF setting. The need to close the gaps in transitional care
delivery and staff support is often mentioned.26 To optimize the
organization and functioning of a TC, the microsystem level (patient,
family, and the care team) should receive support from the
mesosystem (hospital) and macrosystem level (governance).27 In
current daily practice, this higher‐level support seems insufficient.
Looking at health care use and clinical outcomes, we found few
significant results. However, most of these are probably not related
to having a transition program in place. The lower FEV1% predicted
values in the TC group compared with the control group hold for the
entire study period, suggesting higher disease severity in the former.
This could also explain the higher number of hospital admissions in
the TC group in the second year after transfer. Also, other factors
outside the scope of this study might have been of influence, such as
differences in practice patterns and preferences despite widely
utilized protocols.
4.1 | Strengths and limitations
This evaluation study included a unique controlled pre‐post design
with a reasonably long study period. The mixed‐methods approach
helped gaining insight into the organization and functioning of the TC
and perceived facilitators and barriers.
The relatively small number of participants may have negatively
impacted the study’s statistical power. Analysis showed some trends
toward better transfer experiences in the TC setting, although few
findings were statistically significant. Furthermore, the study was
conducted in two academic medical centers in the Netherlands, using
different electronic medical record systems. Insight into clinic atten-
dance around the time of transfer was limited by the variation in
registration of scheduled consultations and the lack of systematic
recording of missed consultations. As both centers are following the
Dutch Guideline Diagnostics and Treatment Cystic Fibrosis3 recom-
mending four multidisciplinary consultations a year, differences regard-
ing scheduled consultations are not expected. We initially intended to
compare both centers on the primary outcome of no‐show after
transfer,19 but unfortunately these data were not available for the
control setting. What we do know, however, is that one patient in
the control setting was lost to follow‐up in the two years after transfer
to AC.
5 | CONCLUSION
We uncovered some benefits of an outpatient TC for young people
with CF, from the perspective of the surveyed young people
themselves and that of the interviewed professionals. No notable
differences in health‐related outcomes were found. Joint con-
sultations in combination with a transition coordinator and an
early started and structured process of preparation were con-
sidered facilitators for successful transitional care. For further
improvement, organizational and financial barriers need to be
addressed. This requires support from the meso and macro levels.
It would be helpful to embed self‐management interventions in
routine transitional care.
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